Spyre Therapeutics, Inc. - SYRE

Include option trades

Include indirect trades

EDGAR CIK

1 Month 3 Month 6 Month 1 Year 2 Years

Buy Breakdown

No buy transactions for this time period.

Transaction	Filed	Name	Type	Shares @ Price	Value	Balance change		Ownership
09/02/2025	09/03/2025	Burrows Scott L Chief Financial Officer CFO	Sell	-18,428 @ $16.26	($299,639.28)	97,994	(-15.83%)	Direct